Symbol
KTTA on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
83,858 shares
Security Ownership %
3.1%

Lawrence Steinman ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

06 Mar 2025 - Lawrence Steinman has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 83,858 shares of Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA). This represents 3.1% ownership of the company. This is the first filing by Lawrence Steinman disclosing ownership of Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).